A stratified phase II study of the aniti-EGFR monoclonal antibody cetuximab (Erbitux TM) for the treatment of recurrent glioblastoma multiforme.

Project Details

AcronymANI40
StatusActive
Effective start/end date17/01/06 → …

Keywords

  • medical images